Syapse, a real-world evidence company accelerating the delivery of precision medicine through the Syapse Learning Health Network™, today announced the appointment of David Pomerantz as Chief Commercial Officer. In his new role as Chief Commercial Officer, Pomerantz will lead the future direction of Syapse’s commercial endeavors and expand its life sciences partnerships across the Syapse Learning Network.
Pomerantz Bio/Background
Mr. Pomerantz brings more than 25 years of account
Read More
Digital Health | News, Analysis, Insights - HIT Consultant
ENvizion Raises $18M for “Waze”-Like Tool for Human Digestive Tract
What You Should Know:
- ENvizion, the FDA 510(k) cleared leader for enteral feeding
tube (EFT) navigation technology, has raised $18M for the ENvue
system, its “Waze”-like tool for the human digestive tract.
- ENvizion’s device enables nurses to navigate the
feeding tube with the help of a real-time 3D map of the patient’s actual body,
and its sensor warns if the tube has veered towards the lungs.
- The company is also partnering with one of the largest private
Read More
Biofourmis Lands $100M to Expand AI-Powered Digital Therapeutics Platform
What You Should Know:
- Boston-based digital therapeutics leader Biofourmis
just closed a $100 million Series C funding round led by SoftBank,
bringing its total funding to $145M.
- Biofourmis will be using the funding to develop, validate and commercialize several released and unreleased digital therapeutics solutions across cardiology, oncology, respiratory, and pain, with a focus on the United States and key Asian markets, including Asia Pacific, China, and
Read More
Google Cloud Awarded Defense Contract to Prototype AI-Enabled Digital Pathology Solution
What You Should Know:
- Today, Google Cloud announced it was selected by the
Defense Innovation Unit (DIU) to prototype an AI-enabled digital pathology
solution at select DoD facilities, with the goal of improving the accuracy of
diagnoses.
- As the VA Center for Innovations in Quality,
Effectiveness, and Safety estimates 5% of outpatient diagnoses are conducted in
error in the U.S., this project will assist physicians who face an overwhelming
amount of data and help ultimately lower
Read More
FDA Approves Medtronic’s Insulin Pump System for People with Type 1 Diabetes
What You Should Know:
- Medtronic announced the U.S. Food and
Drug Administration (FDA) approval of the MiniMed™ 770G hybrid insulin pump
system with smartphone connectivity and an expanded age indication to patients
with Type 1 diabetes aged 2 and up ― the lowest age indication by the FDA for
an automated insulin pump system.
- The new
MiniMed 770G system comes with the Guardian™ Sensor 34, the MiniMed™ Mobile app
(compatible with both iPhone and Android), and Roche Accu-Chek®
Read More
FCC, HHS, and USDA Team Up for Rural Telehealth Initiative Task Force
What You Should Know:
- Agencies sign a memorandum of understanding to establish an interagency Rural Telehealth Initiative Task Force comprised of representatives from each agency to keep rural Americans connected to vital health services.
The Federal Communications Commission
(FCC), U.S. Department of Health and Human
Services (HHS), and U.S. Department of
Agriculture (USDA) today announced that they have signed a Memorandum
of Understanding to work together on the Rural Telehealth
Read More
New Voice-Based App Enables Behavioral Health Measurement Anytime, Anywhere
What You Should Know:
- Ellipsis Health launches new voice-based Rising
Higher app, enabling behavioral health measurement anytime, anywhere.
- The
HIPAA-compliant platform facilitates longitudinal visibility into behavioral health symptoms
for enhanced clinical decision support.
Ellipsis Health,
pioneer of the first commercial-grade voice-based vital signs to
quantify and manage depression and anxiety symptoms at scale, has announced
Read More
BioIQ Appoints Former Walmart Health Exec, Sean Slovenski CEO
What You Should Know:
- Sean Slovenski, former Humana and Walmart Health exec
was recently announced as CEO of testing company, BioIQ. Sean turned to testing
when he noticed a massive failure of the industry to adapt during the COVID
crisis.
- The company has the capacity to test 500,000 per day
without ever owning a lab. Instead, they have a national network of labs that
enables them to be more agile and scalable bypassing the challenges others are
facing, including supply chain
Read More
Lyra Health Reaches $1.1B Valuation After $110M Series D to Meet Demand for Teletherapy
What You Should Know:
- Mental health benefits provider Lyra Health raises $110M
in Series D funding, bringing its valuation to $1.1 billion.
- Lyra has grown significantly in 2020. So far this year,
the company has added more than 800,000 new members to the population eligible
to receive Lyra benefits, bringing its total member population to more than 1.5
million.
- Amid, the COVID-19 pandemic, Lyra is focused on
expanding its enhanced teletherapy offering — Lyra Blended Care —
Read More
Sonde Health Acquires NeuroLex Lab’s Voice-Based Survey Platform
What You Should Know:
- Sonde Health acquires NeuroLex Laboratories, Inc. to forms
one of the world’s preeminent biobanks focused on vocal biomarkers.
- NeuroLex’s core product, SurveyLex, makes it easy to
create and distribute voice surveys in less than a minute as URL links through
web browsers.
Sonde Health, a
Boston-based digital vocal biomarker technology platform announced it has acquired
NeuroLex Laboratories, Inc., a leading
voice-enabled survey and data acquisition platform.
Read More
